Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $18.5100 (2.72%) ($18.1600 - $18.5700) on Tue. Apr. 14, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.92% (three month average) | RSI | 61 | Latest Price | $18.5100(2.72%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.4% a day on average for past five trading days. | Weekly Trend | HALO advances 1.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(51%) IWO(50%) IWM(45%) ARKG(44%) IWC(44%) | Factors Impacting HALO price | HALO will decline at least -1.96% in a week (0% probabilities). VIXM(-31%) VXX(-15%) UUP(-13%) TLT(-3%) IYT(2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.96% (StdDev 3.92%) | Hourly BBV | 0 () | Intraday Trend | 0.1% | | | |
|
5 Day Moving Average | $17.77(4.16%) | 10 Day Moving Average | $17.38(6.5%) | 20 Day Moving Average | $16.9(9.53%) | To recent high | -15.2% | To recent low | 33.2% | Market Cap | $2.53b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |